Zeinab A M Afify, Mary M Taj, Manuela Orjuela-Grimm, Kavitha Srivatsa, Tamara P Miller, Holly J Edington, Mansi Dalal, Joanna Robles, James B Ford, Matthew J Ehrhardt, Tonya J Ureda, Jeremy D Rubinstein, Sarah McCormack, Julie M Rivers, Karen M Chisholm, Madison K Kavanaugh, Andrew J Bukowinski, Erika D Friehling, Maegan C Ford, Sonika N Reddy, Lianna J Marks, Christine Moore Smith, Clinton C Mason
BACKGROUND: Pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disorder [EBV(-)M-PTLD] comprises approximately 10% of M-PTLD. No large multi-institutional pediatric-specific reports on treatment and outcome are available. METHODS: A multi-institutional retrospective review of solid organ recipients diagnosed with EBV(-)M-PTLD aged ≤21 years between 2001 and 2020 in 12 centers in the United States and United Kingdom was performed, including demographics, staging, treatment, and outcomes data...
March 1, 2023: Cancer